Lumida
/RGLS
⌘K
Regulus Therapeutics Inc

Regulus Therapeutics Inc

RGLS
$8.16USD+0.25%+0.02 today

MARKET CAP

565.0M

P/E (TTM)

FWD P/E

DAY RANGE

$8 – $8

52W RANGE

$1
$8
STATEMENT·Income statement
USD · GAAP
METRICFY 2016FY 2017FY 2018FY 2019FY 2020TREND
Sales, Adj.$1.2M$72,000$72,000$6.8M$10.0M
YoY %-94.2%-94.0%+9388.9%+46.5%
P / Sales
EV / Sales
Gross Profit, Adj.$1.2M$72,000$72,000$6.8M$10.0M
YoY %-94.2%-94.0%+9388.9%+46.5%
Margin %100.0%100.0%100.0%100.0%100.0%
EV / Gross Profit
EBITDA, Adj.$-79.2M$-67.6M$-44.5M$-15.9M$-13.7M
YoY %-49.0%+14.7%+34.2%+64.3%+13.9%
Margin %-6635.3%-93898.6%-61806.9%-232.8%-136.8%
EV / EBITDA
EBIT$-81.5M$-70.1M$-46.8M$-16.8M$-14.2M
YoY %-48.8%+14.0%+33.3%+64.0%+15.9%
Margin %-6826.0%-97404.2%-64948.6%-246.4%-141.5%
EV / EBIT
Net Income$-81.8M$-71.9M$-48.7M$-18.6M$-15.7M
YoY %-46.8%+12.1%+32.3%+61.8%+15.4%
Net Margin-6853.9%-99868.1%-67651.4%-272.1%-157.2%
EPS (GAAP)-$185.90-$114.70-$55.90-$10.80-$4.50
YoY %-43.4%+38.3%+51.3%+80.7%+58.3%